UN-IN WUCHIEN-CHING HUNGSUI-YUAN CHANGJhong Y.-T.HSIN-YUN SUNJANN-TAY WANGSZU-MIN HSIEHWANG-HUEI SHENGLiu W.-C.SHAN-CHWEN CHANGYEE-CHUN CHEN2020-06-182020-06-1820170269-9370https://scholars.lib.ntu.edu.tw/handle/123456789/503486[SDGs]SDG3C reactive protein; ciprofloxacin; gamma interferon antibody; HLA DQB1 antigen; HLA DRB1 antigen; lamivudine; neutralizing antibody; nevirapine; tenofovir; antiretrovirus agent; autoantibody; gamma interferon; interferon gamma (1-39); neutralizing antibody; peptide fragment; adult; antibiotic therapy; antibody titer; antiretroviral therapy; atypical mycobacteriosis; bacterial arthritis; blood culture; case report; cell count; clinical article; debridement; enzyme linked immunosorbent assay; granuloma; hip pain; histopathology; hospital admission; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; Letter; lumbar spine; lymphocyte subpopulation; male; monocyte; nuclear magnetic resonance imaging; osteomyelitis; priority journal; protein blood level; Salmonella; salmonellosis; spondylitis; treatment response; AIDS related complex; atypical mycobacteriosis; blood; complication; immunology; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antibodies, Neutralizing; Autoantibodies; HIV Infections; Humans; Interferon-gamma; Male; Mycobacterium avium-intracellulare Infection; Peptide Fragmentsletter10.1097/QAD.0000000000001644291209022-s2.0-85033777874